Association of lipase lipoprotein polymorphisms with high-density lipoprotein and triglycerides in elderly men

Genetics and Molecular Research

Volumn 9, Issue 1, 2010, Pages 89-96

  Araujo L M Q ^a   Cendoroglo, M S ^a   Gigek, C O ^a   Chen, E S ^a   Smith, M D A C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Elderly; HDL cholesterol; Lipoprotein lipase; Polymorphism; Triglycerides

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPID; LIPOPROTEIN LIPASE; TRIACYLGLYCEROL; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

AGED; ALLELE; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DNA POLYMORPHISM; ENZYME BLOOD LEVEL; GENE FREQUENCY; HAPLOTYPE; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK ASSESSMENT; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; BRAZIL; CHEMISTRY; EXON; GENETIC POLYMORPHISM; GENETICS; INTRON; X CHROMOSOMAL INHERITANCE;

AGED; AGED, 80 AND OVER; BRAZIL; DEOXYRIBONUCLEASE HINDIII; EXONS; GENE FREQUENCY; GENES, X-LINKED; HAPLOTYPES; HUMANS; INTRONS; LIPOPROTEIN LIPASE; LIPOPROTEINS, HDL; MALE; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 77649269343     PISSN: None     EISSN: 16765680     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Ahn YI, Kamboh MI, Hamman RF, Cole SA, et al. (1993). Two DNA polymorphisms in the lipoprotein lipase gene and their associations with factors related to cardiovascular disease. J. Lipid Res. 34: 421-428.
2. Almeida KA, Schreiber R, Amancio RF, Bydlowski SP, et al. (2003). Metabolism of chylomicron-like emulsions in carriers of the S447X lipoprotein lipase polymorphism. Clin. Chim. Acta 335: 157-163.
3. Almeida KA, Strunz CM, Maranhao RC and Mansur AP (2007). The S447X polymorphism of lipoprotein lipase: effect on the incidence of premature coronary disease and on plasma lipids. Arq. Bras. Cardiol. 88: 297-303.
4. Anonymous (2001). Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285: 2486-2497.
5. Assmann G (2004). Symposium introduction: Improved cardiovascular risk reduction: the evidence for raising HDL cholesterol. Br. J. Cardiol. 11: S1-S2.
6. Assmann G and Gotto AM Jr (2004). HDL cholesterol and protective factors in atherosclerosis. Circulation 109: III-8-III-14.
7. Barreto SM, Passos VM, Cardoso AR and Lima-Costa MF (2003). Quantifying the risk of coronary artery disease in a community: the Bambui Project. Arq. Bras. Cardiol. 81: 549-561.
8. Chen Q, Razzaghi H, Demirci FY and Kamboh MI (2008). Functional significance of lipoprotein lipase HindIII polymorphism associated with the risk of coronary artery disease. Atherosclerosis 200: 102-108.
9. Chen W, Srinivasan SR, Elkasabany A, Ellsworth DL, et al. (2001). Influence of lipoprotein lipase serine 447 stop polymorphism on tracking of triglycerides and HDL cholesterol from childhood to adulthood and familial risk of coronary artery disease: the Bogalusa Heart Study. Atherosclerosis 159: 367-373.
10. Emery AE (1986). Methodology in Medical Genetics - An Introduction to Statistical Methods. Longman, Edinburgh.
11. Garnier-Gere P and Dillmann C (1992). A computer program for testing pairwise linkage disequilibria in subdivided populations. J. Hered. 83: 239.
12. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, et al. (1997). Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 96: 2520-2525.
13. Gigek CO, Chen ES, Cendoroglo MS, Ramos LR, et al. (2007). Association of lipase lipoprotein polymorphisms with myocardial infarction and lipid levels. Clin. Chem. Lab. Med. 45: 599-604.
14. Hallman DM, Srinivasan SR, Elkasabany A, Boerwinkle E, et al. (2001). The Ser(447)-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: the Bogalusa Heart Study. Metabolism 50: 894-904.
15. Hata A, Robertson M, Emi M and Lalouel JM (1990). Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res. 18: 5407-5411.
16. Humphries SE, Nicaud V, Margalef J, Tiret L, et al. (1998). Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: the European Atherosclerosis Research Study (EARS). Arterioscler. Thromb. Vasc. Biol. 18: 526-534.
17. Kobayashi J, Nishida T, Ameis D, Stahnke G, et al. (1992). A heterozygous mutation (the codon for Ser447 - a stop codon) in lipoprotein lipase contributes to a defect in lipid interface recognition in a case with type I hyperlipidemia. Biochem. Biophys. Res. Commun. 182: 70-77.
18. Lahiri DK and Nurnberger JI Jr (1991). A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444.
19. Lindenstrom E, Boysen G and Nyboe J (1994). Influence of total cholesterol, high density lipoprotein cholesterol, and triglycerides on risk of cerebrovascular disease: the Copenhagen City Heart Study. BMJ 309: 11-15.
20. Malygina NA, Melent'ev AS, Kostomarova IV, Melent'ev IA, et al. (2001). [Connection of HindIII-polymorphism in the lipoprotein lipase gene with myocardial infarct and life span in elderly ischemic heart disease patients]. Mol. Biol. 35: 787-791.
21. Mattu RK, Needham EW, Morgan R, Rees A, et al. (1994). DNA variants at the LPL gene locus associate with angiographically defined severity of atherosclerosis and serum lipoprotein levels in a Welsh population. Arterioscler. Thromb. 14: 1090-1097.
22. McGladdery SH, Pimstone SN, Clee SM, Bowden JF, et al. (2001). Common mutations in the lipoprotein lipase gene (LPL): effects on HDL-cholesterol levels in a Chinese Canadian population. Atherosclerosis 156: 401-407.
23. Morrison AC, Ballantyne CM, Bray M, Chambless LE, et al. (2002). LPL polymorphism predicts stroke risk in men. Genet. Epidemiol. 22: 233-242.
24. Nicklas BJ, Ferrell RE, Rogus EM, Berman DM, et al. (2000). Lipoprotein lipase gene variation is associated with adipose tissue lipoprotein lipase activity, and lipoprotein lipid and glucose concentrations in overweight postmenopausal women. Hum. Genet. 106: 420-424.
25. Razzaghi H, Aston CE, Hamman RF and Kamboh MI (2000). Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum. Genet. 107: 257-267.
26. Sepetiba RJ, Andrade J, Hirata RD, Hirata MH, et al. (2007). Lipoprotein lipase PvuII polymorphism is associated with variations in serum lipid levels in non-diabetic pregnant women. Braz. J. Med. Biol. Res. 40: 919-926.
27. Sposito AC, Caramelli B, Fonseca FA, Bertolami MC, et al. (2007). [IV Brazilian Guideline for Dyslipidemia and Atherosclerosis Prevention: Department of Atherosclerosis of Brazilian Society of Cardiology]. Arq. Bras. Cardiol. 88 (Suppl 1): 2-19.
28. Thu NN, Mai TT, Ohmori R, Kuroki M, et al. (2006). Plasma triglyceride and HDL-cholesterol concentrations in Vietnamese girls are affected by lipoprotein lipase, but not apolipoprotein CIII polymorphism. J. Nutr. 136: 1488-1492.
29. Van Bockxmeer FM, Liu Q, Mamotte C, Burke V, et al. (2001). Lipoprotein lipase D9N, N291S and S447X polymorphisms: their influence on premature coronary heart disease and plasma lipids. Atherosclerosis 157: 123-129.
30. Windler E, Schoffauer M and Zyriax BC (2007). The significance of low HDL-cholesterol levels in an ageing society at increased risk for cardiovascular disease. Diab. Vasc. Dis. Res. 4: 136-142.
31. Wolf PA, D'Agostino RB, O'Neal MA, Sytkowski P, et al. (1992). Secular trends in stroke incidence and mortality. The Framingham Study. Stroke 23: 1551-1555.